Informations générales (source: ClinicalTrials.gov)
Management of Patients on Long Term Anticoagulation Therapy Undergoing a Primary Total Hip of Knee Replacement (ADELC)
Observational
Association pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique (Voir sur ClinicalTrials)
juin 2016
juillet 2019
29 juin 2024
It is a multicenter, prospective, observational study of standard care. This study
analyses the care of patients on long term effective anticoagulation therapy (ADELC)
during a primary hip or knee arthroplasty.
The objectives of the study are to:
1. Identify clinical practices set up for patient care
2. Assess the type and the frequency of perioperative complications
3. Look for factors, related to patients or treatments, associated with the occurrence
of these complications.
The main objective is to estimate the risks, adjusted and not, of postoperative
complications associated to a long term anticoagulation by comparing patients under
anticoagulation to a control group of patients having the same interventions but who are
not under anticoagulation.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| EFS IDF SITE COCHIN | David Biau | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Adult ≥ 18 years
- Programmed for primary hip or knee arthroplasty.
- Effective dose of anticoagulant drugs intake for more than 1 month with the
intention to resume it after the intervention for ADELC cohort; no effective dose of
anticoagulant drugs intake for the control cohort.
- Adult ≥ 18 years
- Programmed for primary hip or knee arthroplasty.
- Effective dose of anticoagulant drugs intake for more than 1 month with the
intention to resume it after the intervention for ADELC cohort; no effective dose of
anticoagulant drugs intake for the control cohort.
- Patient non opposition